Modulating effects of L-arginine on cytokine-stimulated lymphocyte migration in vitro

Microsurgery

Volumn 23, Issue 3, 2003, Pages 262-267

  Isenberg, J Scott ^a,b  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GAMMA INTERFERON; NITRIC OXIDE SYNTHASE;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; EVALUATION; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; INFLAMMATORY CELL; LYMPHOCYTE MIGRATION; MOLECULAR MODEL; MONONUCLEAR CELL; NEWBORN; PRIORITY JOURNAL; REPERFUSION INJURY; UMBILICAL VEIN;

ARGININE; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIUM, VASCULAR; HUMANS; INTERFERON TYPE II; LYMPHOCYTES; NG-NITROARGININE METHYL ESTER; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 0037827201     PISSN: 07381085     EISSN: None     Source Type: Journal    
DOI: 10.1002/micr.10119     Document Type: Article

References (36)

1. Hallock G. Microleaps in the progression of flaps and grafts. Clin Plast Surg 1996;23:117-138.
2. Neligan P, Boyd B. Reconstruction of the cranial base. Clin Plast Surg 1998;22:71.
3. Khouri RK, Cooley BC, Kunselman AR, Landis JR, Yeramian P, Ingram D, Natarajan N, Renes CO, Wallemark C. A prospective study of microvascular free-flap surgery and outcome. Plast Reconstr Surg 1998;102:711-721.
4. Hallock G. The fate of the second-attempt free flap. Ann Plast Surg 2001;47:41.
5. Chepeha DB, Nussenbaum MD, Bradford CR, et al. Leech therapy for patients with surgically unsalvageable venous obstruction after revascularized free tissue transfer. Arch Otolaryngol Head Neck Surg 2002;128:960.
6. Hirigoyen MB, Zhang W, Gordon RE, et al. Additional benefit of heparin in the thrombolytic salvage of ischemic skin flaps. Ann Plast Surg 1995;35:612.
7. Hidalgo DA, Jones CS. The role of emergent exploration in free-tissue transfer: a review of 150 consecutive cases. Plast Reconstr Surg 1990;86:492.
8. Pober J, Contran R. Cytokines and endothelial biology. Physiol Rev 1990;70:427.
9. Gimbrone M. Vascular endothelium in health and disease. In: Harber E, editor. Molecular cardiovascular medicine. New York: Scientific American Medicine; 1995.
10. Homer K, Wanstall J. Cyclic GMP-independent relaxation of rat pulmonary artery by spermine NONOate, a diazeiumdiolate nitric oxide donor. Br J Pharmacol 2000;4:673.
11. Daha M, Mittenburg A, Hiemstra P, et al. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in-vitro. Eur J Immunol 1998;18:783.
12. Sancho D, Yanez-Mo M, Tejedor R, et al. Activation of peripheral blood T-cells by interaction and migration through endothelium: role of lymphocyte function antigen-1/intracellular adhesion molecule and interlukin-15. Blood 1999;93:886.
13. Jaffe E, Nachman R, Becker C, et al. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1993;52:2745.
14. Jarvis J, Xu C, Wand W. Immune complex size and complement regulate cytokine production by peripheral blood mononuclear cells. Clin Immunol 1999;93:274.
15. Wei F, Chang Y, Lee K, et al. Comparison of skeletal muscle circulation between clamp ischemia and microsurgical ischemia. Microsurgery 1996;17:123.
16. Ozer K, Gokhan A, Zins J, et al. In vivo microscopic assessment of cremasteric microcirculation during hindlimb allograft rejection in rats. Plast Reconstr Surg 1999;103:1949.
17. Kruger Z, Dogan T, Zhnag F, et al. Effects of VEGF administration following ischemia on survival of the gracilis muscle flap in the rat. Ann Plast Surg 1999;43:172.
18. Rucker M, Roesken F, Schafer T, et al. In vivo analysis of the microcirculation of osteomyocutaneous flaps using fluorescence microscopy. Br J Plast Surg 1999;52:644.
19. Kurose I, Wolf R, Grisham MB, et al. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Cir Res 1994;74:376.
20. Baatz H, Pleyer U. Modulation of leukocyte-endothelium interaction by nitric oxide synthase inhibitors: effects of leukocyte adhesion in endotoxin-induced uveitis. Inflamm Res 2001;50:534.
21. Xiao S, Cu S, Jarvis J. Clq-bearing immune complexes induce IL-8 secretion in human umbilical vein endothelium (HUVEC) through tyrosine kinase- and mitogen-activated protein kinase dependent mechanisms: evidence that the 126 kD phagocytic C1q receptor mediates immune complex activation of HUVEC. Clin Exp Immunol 2001;125:360.
22. Lal B, Varma S, Pappas P, et al. VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric oxide synthase and MAP kinase pathways. Microvasc Res 2001;62:252.
23. Ozaki M, Kawashima S, Hirase T, et al. Overexpression of endothelial nitric oxide synthase in endothelial cells is protective against ischemia-reperfusion injury in mouse skeletal muscle. Am J Pathol 2002;160:1335.
24. Tsui J, Souza D, Filbey D, et al. Preserved endothelial integrity and nitric oxide synthase in saphenous vein grafts harvested by a "no-touch" technique. Br J Plast Surg 2001;88:1209.
25. Schutte H, Mayer K, Burger H, et al. Endogenous nitric oxide synthesis and vascular leakage in ischemic-reperfused rabbit lungs. Am J Repsir Crit Care Med 2001;164:412.
26. Butt E, Bernhardt M, Smolenski A, et al. Endothelial nitric oxide synthase is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases. J Biol Chem 2000;275:5179.
27. Hardy T, May J. Coordinate regulation of L-arginine uptake and nitric oxide synthase activity in cultured endothelial cells. Free Radic Biol Med 2002;32:122-131.
28. Ercocen AR, Apaydin I, Emiroglu M, et al. The effects of L-arginine and iloprost on the viability of random skin flaps in rats. Scand J Plast Reconstr Surg 1998;32:19.
29. Cordeiro PG, Santamaria E, Hu QY. Use of a nitric oxide precursor to protect pig myocutaneous flaps from ischemia-reperfusion injury. Plast Reconstr Surg 1990;102:2040.
30. Lui K, Chen L, Seaber A, et al. S-nitroso-N-acetylcysteine protects skeletal muscle against reperfusion injury. Microsurgery 1998;18:299.
31. Klabunde RE, Anderson DE. Role of nitric oxide and reactive oxygen species in platelet-activating factor-induced microvascular leakage. J Vasc Res 2002;39:238.
32. Lovett JE, Fink BF, Bernard A, et al. Analysis of nitric oxide activity in prevention of reperfusion injury. Ann Plast Surg 2001;46:269.
33. Khiabani KT, Kerrigan CL. The effects of the nitric oxide donor SIN-1 on ischemia-reperfused cutaneous and myocutaneous flaps. Plast Reconstr Surg 2002;110:169.
34. Salas A, Panes J, Rosenblom CL, et al. Differential effects of a nitric oxide donor on reperfusion-induced microvascular dysfunction in diabetic and non-diabetic rats. Diabetologia 1999;42:1350.
35. 635 by a protein kinase A-dependent mechanism. Am J Physiol Heart Circ Physiol 2002;283:1819.
36. 1179 by Akt-independent mechanism: role of protein kinase A. J Biol Chem 2002;277:3388.